ArticleLancet (London, England)2020
Immunosuppression for hyperinflammation in COVID-19: a double-edged sword?
Andrew I Ritchie et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
191 papers cite itlatest 60 shown
this paperpooled ittrialcites it